Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Steadman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Pharmacology|July 28, 2009
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug ScreenJohn F Deeken, Robert W Robey, Suneet Shukla, et al.
Pharmacogenetics and Genomics|January 10, 2014
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicineMichael Harris, Krithika Bhuvaneshwar, Thanemozhi Natarajan, et al.
Cancer|February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Deepa Subramaniam, et al.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct DegradersGeoffray Leriche, Farhana Barmare, Julia I Toth, et al.
Scientific Reports|July 17, 2015
Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanesSamantha Morley, Sungyong You, Sara Pollan, et al.
Cancer Research|August 30, 2018
Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Pharmacology|July 28, 2009
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug ScreenJohn F Deeken, Robert W Robey, Suneet Shukla, et al.
Pharmacogenetics and Genomics|January 10, 2014
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicineMichael Harris, Krithika Bhuvaneshwar, Thanemozhi Natarajan, et al.
Cancer|February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Deepa Subramaniam, et al.
Molecular Cancer Therapeutics|July 5, 2024
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct DegradersGeoffray Leriche, Farhana Barmare, Julia I Toth, et al.
Scientific Reports|July 17, 2015
Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanesSamantha Morley, Sungyong You, Sara Pollan, et al.
Cancer Research|August 30, 2018
Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
Pageof 2